A randomized double blind clinical trial of two GnRH analogs for the treatment of cystic ovaries in dairy cows.
A randomized double blind clinical trial was conducted to compare the efficacy of the gonadotrophin-releasing hormone, buserelin, to that of the hormone gonadorelin for the treatment of bovine ovarian cysts. Two hundred and sixty five cows with a clinical diagnosis of follicular cysts were included in the study. At 30 days post treatment 85% of the gonadorelin and 89% of the buserelin treatment groups no longer had a palpable ovarian cyst. No significant differences were found between treatment groups in the number of cows bred by 90 days post treatment, conception rate by 90 days post treatment, services per conception, milk progesterone at 30 days post treatment, days post treatment to first heat, and days post treatment to conception.
D000818:Animals; D002064:Buserelin / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006728:Hormones / Q000627:therapeutic use*; D010048:Ovarian Cysts / Q000188:drug therapy / Q000662:veterinary*; D011897:Random Allocation
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin